Medicines Co. beats Street

The Medicines Co. (NASDAQ:MDCO) reported 2Q10 GAAP EPS of $0.29, beating by $0.06 the Street's estimate of $0.23 and up from $0.07 in 2Q09. Second quarter revenues were $110.1 million, up from $104.2 ...